Author:
Hernandez-Juarez Jesus,Garcia-Latorre Ethel A,Moreno-Hernandez Manuel,Moran-Perez Jose Fernando,Rodriguez-Escobedo Miguel Angel,Cogque-Hernandez Gerardo,Julián-Nacer Rubén,Hernandez-Giron Xochitl,Palafox-Gomez Rosalia,Isordia-Salas Irma,Majluf-Cruz Abraham
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,Reproductive Medicine
Reference42 articles.
1. World Health Organization: Cardiovascular Disease and Steroid Hormone Contraception. Report of a WHO Scientific group. World Health Organ Tech Rep Ser. 1998, 877: 1-89.
2. Instituto Nacional de Estadística, Geografía e Informática. Mexico: Estadísticas generales.http://dgcnesyp.inegi.gob.mx,
3. Dittrich R, Parker L, Rosen JB, Shangold G, Creasy GW, Fisher AC, Ortho Evra/Evra 001 Study Group: Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicentre, dose–response study. Am J Obstet Gynecol. 2002, 186: 15-20. 10.1067/mob.2002.118844.
4. Janssen-Cilag International NV: Evra transdermal patch. Summary of product characteristics.http://www.janssen-cilag.co.uk/product/pdf/spc/00121.pdf,
5. Abrams LS, Skee D, Natarajan J, Wong FA: Pharmacokinetic overview of Ortho EvraTM/EvraTM. Fertil Steril. 2002, 77 (Suppl 1): S3-S12.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献